We are live on
!
Find out more
BW
Browning West Portfolio holdings
AUM
$1.69B
1-Year Est. Return
9.16%
This Fund
S&P 500
This Quarter
Est. Return
+1.36%
1 Year Est. Return
+9.16%
3 Year Est. Return
+96.83%
5 Year Est. Return
+108.19%
10 Year Est. Return
–
AUM
$1.69B
AUM Growth
+$72.9M
(+4.5%)
Cap. Flow
+$53.7M
Cap. Flow
% of AUM
3.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
2
Reduced
1
Closed
–
Avg Time Held
9.3
quarters
Top 10 Avg Time Held
9.3
quarters
Top 20 Avg Time Held
9.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGI
Somnigroup International
SGI
|
+$34.7M |
| 2 |
Cooper Companies
COO
|
+$14.1M |
| 3 |
The Ensign Group
ENSG
|
+$5.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAE Inc
CAE
|
+$346K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.49% |
| 2 | Healthcare | 30.81% |
| 3 | Industrials | 18.69% |
Similar funds
GAI
CWG
BCAM
KP
KFGK
MCM
AFM
Browning West's Q2 2026 Portfolio in Review
As of Q2 2026, Browning West held 6 positions worth $1.69B, up 4.5% from $1.62B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Browning West deployed $53.7M of net new capital in Q2 2026, opening 1 new position and adding to 2 existing holdings. Its largest new stake was The Ensign Group: 30,000 shares worth $4.81M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 49% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was CAE Inc, an estimated $346K trimmed.
- Browning West's largest Q2 2026 buy was The Ensign Group: 30,000 shares worth $4.81M.
- Browning West added most to Somnigroup International in Q2 2026, an estimated $34.7M increase.
- Browning West's biggest Q2 2026 reduction was CAE Inc, cutting an estimated $346K.
- Browning West's ten largest holdings make up 100% of its $1.69B portfolio in Q2 2026.
- Browning West opened 1 new position and closed 0 in Q2 2026.
- Browning West's portfolio value rose 4.5% quarter-over-quarter to $1.69B.
Based on Browning West's 13F filing for Q2 2026, filed 14 Aug 2026.